From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

Clinical trials often face low accrual and retention, and involving communities in their planning and conduct is crucial to ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed ...

C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

A key House committee has blocked a bipartisan amendment to a spending bill that would have given the Department of Defense ...

Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each ...

Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand ...

The continuation of enrollment further expands Clearmind’s international clinical network and strengthens the growing interest in CMND-100 as a potentially groundbreaking treatment for AUD.